FDA-Device2026-02-11Class IIPROCESSING DEFECT
Medtronic MiniMed 780G insulin pump recalled for software error causing insulin delivery suspension
OTHERNationwide distribution
Check your MiniMed 780G pump software version
Some Medtronic MiniMed 780G insulin pumps with software version 6.60 may experience a software timing issue that triggers an error code and stops insulin delivery. This affects specific catalog numbers (MMT-1884, MMT-1886) with certain serial numbers.
- Check your pump's software version (version 6.60 is affected)
- Compare your pump's serial number to the FDA recall list
- Contact Medtronic MiniMed immediately if your pump matches the affected serial numbers
- Do not ignore Pump Error 43 or Pump Error 41 messages—contact Medtronic right away
Hazard
A software timing and processor communication issue in MiniMed" 780G software version 6.60 may trigger Pump Error 43 and/or Pump Error 41, resulting in suspension of insulin delivery.
Sold states
Worldwide - U.S. National distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV. The country of Israel.
Affected count
577 units
Manufactured in
18000 Devonshire St, N/A, Northridge, CA, United States
Products
MiniMed 780G Insulin Pump Catalog Numbers: MMT-1884 MMT-1886 With Software Version 6.60 The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more. The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1238-2026More Medtronic MiniMed, Inc. recalls
- FDA-Device2026-04-08Medtronic MiniMed insulin pumps recalled for incorrect insulin delivery based on pump position
- FDA-Device2026-04-08Medtronic MiniMed Paradigm insulin pumps recalled for incorrect insulin delivery based on pump position
- FDA-Device2026-04-08Medtronic MiniMed insulin pumps recalled for incorrect insulin delivery based on pump position
- FDA-Device2026-04-08Medtronic MiniMed insulin pumps recalled for incorrect insulin delivery based on pump position
- FDA-Device2026-04-08Medtronic MiniMed insulin pumps recalled for incorrect insulin delivery based on pump position
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief